Advanced search
Publication Cover
Drug Design, Development and Therapy Volume 13, 2019 - Issue
Submit an article Journal homepage
114
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Generic Tacrolimus (Tacrobell®) Shows Comparable Outcomes to Brand-Name Tacrolimus in the Long-Term Period After Adult Deceased Donor Liver Transplantation

Jong Man Kim1 Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of KoreaORCID Iconhttps://orcid.org/0000-0002-1903-8354
ORCID Icon,
Jae-Won Joh1 Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of KoreaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-1732-6210
ORCID Icon,
Gyu-Seong Choi1 Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
&
Suk-Koo Lee1 Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
Pages 4431-4438 | Published online: 31 Dec 2019

References

  • Group USMFLS. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med. 1994;331(17):1110–1115. doi:10.1056/NEJM1994102733117027523946
  • Li XC, Turka LA. An update on regulatory T cells in transplant tolerance and rejection. Nat Rev Nephrol. 2010;6(10):577–583. doi:10.1038/nrneph.2010.10120683480
  • Molnar AO, Fergusson D, Tsampalieros AK, et al. Generic immunosuppression in solid organ transplantation: systematic review and meta-analysis. BMJ. 2015;350:h3163. doi:10.1136/bmj.h316326101226
  • Taube D, Jones G, O’Beirne J, et al. Generic tacrolimus in solid organ transplantation. Clin Transplant. 2014;28(5):623–632. doi:10.1111/ctr.2014.28.issue-524750309
  • Spence MM, Nguyen LM, Hui RL, Chan J. Evaluation of clinical and safety outcomes associated with conversion from brand-name to generic tacrolimus in transplant recipients enrolled in an integrated health care system. Pharmacotherapy. 2012;32(11):981–987. doi:10.1002/phar.2012.32.issue-1123074134
  • Yu YD, Lee SG, Joh JW, et al. Results of a Phase 4 trial of Tacrobell(R) in liver transplantation patients: a multicenter study in South Korea. Hepatogastroenterology. 2012;59(114):357–363. doi:10.5754/hge1147221940371
  • Liu Q, Smith AR, Park JM, et al. The adoption of generic immunosuppressant medications in kidney, liver, and heart transplantation among recipients in Colorado or nationally with Medicare part D. Am J Transplant. 2018;18(7):1764–1773. doi:10.1111/ajt.1472229603899
  • Park K, Kim YS, Kwon KI, Park MS, Lee YJ, Kim KH. A randomized, open-label, two-period, crossover bioavailability study of two oral formulations of tacrolimus in healthy Korean adults. Clin Ther. 2007;29(1):154–162. doi:10.1016/j.clinthera.2007.01.01617379055
  • Choi HJ, Kim DG, Kwak BJ, Han JH, Hong TH, You YK. Comparison of the long-term efficacy and safety of generic tacrolimus, Tacrobell, with Prograf in liver transplant recipients. Drug Des Devel Ther. 2018;12:295–301. doi:10.2147/DDDT
  • Kim JM, Kwon CHD, Joh JW, et al. ABO-incompatible living donor liver transplantation with rituximab and total plasma exchange does not increase hepatocellular carcinoma recurrence. Transplantation. 2018;102(10):1695–1701. doi:10.1097/TP.000000000000215429494419
  • Kim JM, Kwon CHD, Joh JW, Choi GS, Kang ES, Lee SK. Comparative peripheral blood t cells analysis between adult Deceased Donor Liver Transplantation (DDLT) and Living Donor Liver Transplantation (LDLT). Ann Transplant. 2017;22:475–483. doi:10.12659/AOT.90309028784939
  • van Gelder T. What is the future of generics in transplantation? Transplantation. 2015;99(11):2269–2273. doi:10.1097/TP.000000000000078226050017
  • Kim JM, Kwon CHD, Joh JW, et al. Differences in peripheral blood lymphocytes between brand-name and generic tacrolimus used in stable liver transplant recipients. Med Princ Pract. 2017;26(3):221–228. doi:10.1159/00045586128092916
  • Ball S. Bioequivalence of twice-daily oral tacrolimus in transplant recipients: more evidence for consensus? PLoS Med. 2017;14(11):e1002429. doi:10.1371/journal.pmed.100242929135980
  • Harrison JJ, Schiff JR, Coursol CJ, et al. Generic immunosuppression in solid organ transplantation: a Canadian perspective. Transplantation. 2012;93(7):657–665. doi:10.1097/TP.0b013e3182445e9d22267158
  • Gil E, Kim JM, Jeon K, et al. Recipient age and mortality after liver transplantation: a population-based cohort study. Transplantation. 2018;102(12):2025–2032. doi:10.1097/TP.000000000000224630153223
  • Kwon JH, Yoon YI, Song GW, et al. Living donor liver transplantation for patients older than age 70 years: a single-center experience. Am J Transplant. 2017;17(11):2890–2900. doi:10.1111/ajt.1435528510341

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.